Joseph M. Tuscano

United States Department of Veterans Affairs

Also affiliated with Patrick Air Force Base, VA Northern California Health Care System, University of California Davis Medical Center, UC Davis Health, UC Davis Comprehensive Cancer Center, University of California, Davis

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma”.

Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma

New England Journal of Medicine(2024)10.1056/nejmoa2405888

N/A

3.4DataRank · unranked

211 citations

Michael LeBlanc, Sharon M. Castellino, Hongli Li, Sarah C. Rutherford, Andrew M. Evens +42 more

Association of Morbid Progression With Overall Survival Among Patients With Multiple Myeloma: Validation of the Progression-free Survival Endpoint

Clinical Lymphoma Myeloma & Leukemia(2020)10.1016/j.clml.2020.12.021

N/A

0DataRank · unranked

7 citations

Thierry Façon, Kejal Parikh, Weiyuan Chung, Shankar Srinivasan, Stanley Kotey +2 more

A Phase I Study of Everolimus and Bendamustine in Patients With Relapsed/Refractory Lymphoid Hematologic Malignancies

Clinical Lymphoma Myeloma & Leukemia(2020)10.1016/j.clml.2020.02.006

N/A

0DataRank · unranked

3 citations

JULIAN R. DAVIS, Brian A. Jonas, Joseph M. Tuscano, Aaron S. Rosenberg, Mehrdad Abedi +1 more

Effect of autologous hematopoietic stem cell transplant on the development of second primary malignancies in multiple myeloma patients

Blood Cancer Journal(2021)10.1038/s41408-020-00400-4

N/A

0DataRank · unranked

23 citations

Ann Brunson, Joseph M. Tuscano, Brian A. Jonas, Rasmus T. Hoeg, Ted Wun +2 more

Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center

Leukemia Research(2022)10.1016/j.leukres.2022.106885

N/A

0DataRank · unranked

8 citations

Benjamin Moskoff, Gwendolyn Ho, Matthew E. Tenold, Tali Azenkot, Margaret L. Krackeler +12 more

Phase I trial of the combination of ibrutinib and lenalidomide of the treatment of patients with MDS who have failed standard therapy or who are unfit for or refuse standard therapy

Leukemia Research(2022)10.1016/j.leukres.2022.106947

N/A

0DataRank · unranked

4 citations

Joseph M. Tuscano, Lihong Qi, Brian A. Jonas, Samantha Fisch

NIVOLUMAB(N)‐AVD IMPROVES PROGRESSION‐FREE SURVIVAL COMPARED TO BRENTUXIMAB VEDOTIN(BV)‐AVD IN ADVANCED STAGE (AS) CLASSIC HODGKIN LYMPHOMA (HL): RESULTS OF SWOG S1826

Hematological Oncology(2023)10.1002/hon.3163_5

N/A

0DataRank · unranked

21 citations

Michael LeBlanc, Sharon M. Castellino, Huilin Li, Sarah C. Rutherford, Andrew M. Evens +41 more

Long-Axial Field-of-View PET Imaging in Patients with Lymphoma

PET Clinics(2024)10.1016/j.cpet.2024.05.005

N/A

0DataRank · unranked

4 citations

Hande Nalbant, Hasan Sari, Felipe Godinez, Fatma Şen, Benjamin A. Spencer +4 more

Model of a Queuing Approach for Patient Accrual in Phase 1 Oncology Studies

JAMA Network Open(2020)10.1001/jamanetworkopen.2020.4787

N/A

0DataRank · unranked

16 citations

Vincent Chung, Joseph M. Tuscano, Tanya Siddiqi, Sagus Sampath, Jeff Longmate +3 more

A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis

Blood Advances(2025)10.1182/bloodadvances.2025016845

N/A

0DataRank · unranked

2 citations

Tamer Othman, Paul Frankel, Christopher Ruel, Christina Poh, Samantha Herbert +20 more